Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	View
JXSS2300012	利妥昔单抗注射液（皮下注射）	rituximab	Injection	Biological Products(3.1)	Import Drug Application	2023-01-18				view
CYSB2300120	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-06-27		Shanghai Henlius Biopharmaceutical Co Ltd		view
JYSB2300192	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-11-07				view
JYSB2101047	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2021-06-04				view
CXSS2200092	利妥昔单抗注射液	rituximab	Injection	Biological Products(3.3)	New Drug Application	2022-12-13		Shanghai Institute of Biological Products Co Ltd		view
JYSB2300018	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-02-07				view
JYSB2300191	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-11-07				view
CXSL2101050	重组抗CD20人鼠嵌合单克隆抗体注射液	rituximab	Injection	Biological Products(3.3)	New Drug Application	2021-04-30		Shandong New Time Pharmaceutical Co Ltd		view
CXSS2200086	利妥昔单抗注射液	rituximab	Injection	Biological Products(3.3)	New Drug Application	2022-10-24		Shenghe (China) Biopharmaceutical Co Ltd		view
JYSB2300017	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-02-07				view
JYSB2300189	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-11-07				view
JYSB2101046	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2021-06-04				view
CXSS2200002	利妥昔单抗注射液	rituximab	Injection	Biological Products(3.3)	New Drug Application	2022-01-11		Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group		view
JYSB2300020	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-02-07				view
JYSB2101048	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2021-06-04				view
JYSB2300190	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-11-07				view
CYSB2200098	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2022-03-28		Shanghai Henlius Biopharmaceutical Co Ltd		view
JYSB2300019	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-02-07				view
BS20020012	利妥昔单抗注射液	rituximab	Injection	Biological Products	Import Drug Application	2002-10-29	上海罗氏制药有限公司	Shanghai Roche Pharmaceutical Co Ltd	Approval Completed-Pending Certificated	view
CYSB2300121	利妥昔单抗注射液	rituximab	Injection	Biological Products	Supplementary Application	2023-06-27		Shanghai Henlius Biopharmaceutical Co Ltd		view